X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.raps.org/news-and-articles/news-articles/2019/6/emas-chmp-rejects-another-drug-approved-by-us-fda
https://www.raps.org/news-and-articles/news-articles/2019/5/emas-chmp-offers-negative-opinion-for-sickle-cell
https://www.raps.org/news-and-articles/news-articles/2019/1/ema-sees-spike-in-medicines-recommendations-in-201?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%204%20January
https://www.prnewswire.com/news-releases/actinium-appoints-robert-n-daly-phd-to-newly-created-role-of-vice-president-head-of-clinical-operations-300707708.html
https://endpts.com/jj-bayer-fail-at-their-second-big-attempt-to-spotlight-a-safe-benefit-for-clot-buster-xarelto-in-vte/
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/07/news_detail_002994.jsp&mid=WC0b01ac058004d5c1
https://www.raps.org/news-and-articles/news-articles/2018/3/ema%E2%80%99s-chmp-rejects-two-drugs-approved-by-us-fda-in
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1
https://endpts.com/helsinn-buys-global-rights-for-skin-cancer-drug-from-actelion-akebia-reels-in-more-cash-for-vadadustat-ema-slams-bevyxxa/
https://seekingalpha.com/article/4133390-portola-pharmaceuticals-early-fda-approval-bevyxxa-pas-entails
https://globenewswire.com/news-release/2017/11/21/1198362/0/en/Portola-Pharmaceuticals-Provides-Update-on-Bevyxxa-betrixaban-Commercial-Launch.html
http://www.pharmatimes.com/news/us_approval_for_portolas_bevyxxa_1197134
http://www.raps.org/Regulatory-Focus/News/2017/04/12/27333/Fast-Start-for-FDA-Drug-Approvals-in-2017/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://globenewswire.com/news-release/2017/02/08/915095/0/en/FDA-Informs-Portola-Pharmaceuticals-at-Mid-Cycle-Review-for-Betrixaban-That-It-Has-Not-Identified-Issues-that-Require-an-Advisory-Committee-Meeting.html
http://www.nasdaq.com/article/ions-scripts-history-ptla-gets-fda-date-strongbridge-slumps-neot-on-watch-20161223-00490
http://www.dddmag.com/news/2016/10/portola-pharmaceuticals-submits-nda-anticoagulant-betrixaban?
Market Place
Share 
